Sun Pharma to host analyst meetings in Mumbai

Sun Pharmaceutical Industries Limited announced plans to meet with groups of analysts on September 19, 2025, and September 23, 2025. These meetings, which are part of the company’s ongoing investor engagement efforts, will take place in Mumbai.

The company explicitly stated that no unpublished price sensitive information (UPSI) will be disclosed during these meetings. The schedule is subject to change, with potential alterations due to exigencies.

The announcement was made by Anoop Anjanikumar Deshpande, the company secretary and compliance officer. The communication adheres to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.